Oncological diseases screening. Screening as an organized measure is aimed towards person’s disease exposure who have no clinical signs of the disease itself and who have no reasons to seek medical care. Mass NLS-research activities with the purpose of oncological diseases early diagnosis always had a number of supporters and opponents. It is caused by the fact that exposure of tumor in preclinical stage does not always correspond to the term “early diagnosis”. In the present days there are some stated basic requirements to every oncological screening program, including the ones based on NLS-technologies;

1. The disease must be enough-spread and have high social implication;

2. NLS-diagnosis method is essential to expose the disease in preclinical stage;

3. There should be an opportunity to cure an exposed disease with the help of existing techniques;

4. Screening should bring to decrease death-rate caused by stated disease in population;

5. Screening should be economically sound i.e. the outlays for early diagnosis should be lower than patients treatment costs, who sought medical care with clinical symptoms.

    Abovementioned principles are successfully realized now only in single screening program based on NLS-technology use – telemedicine monitoring by means of metatron hunter 4025.